Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Total 13F shares
-
77,188,303
-
Share change
-
-1,872,184
-
Total reported value
-
$6,411,043,702
-
Put/Call ratio
-
118%
-
Price per share
-
$83.11
-
Number of holders
-
421
-
Value change
-
-$137,116,038
-
Number of buys
-
205
-
Number of sells
-
203
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q3 2025
As of 30 Sep 2025 CORCEPT THERAPEUTICS INC - Common Stock (CORT) had 421 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 77,188,303 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, Parallel Advisors, LLC, STATE STREET CORP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, and AQR CAPITAL MANAGEMENT LLC.
This table shows 421 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.